These findings define a MET-mediated oncogenic axis in THCA progression, wherein MET coordinately activates ERK/STAT3 signaling cascades, enhances expression of EMT-transcription factors, upregulates extracellular matrix remodeling proteins, and collectively driving tumor invasion and metastasis. The gene discussed is MAPK1; the disease is neoplasm.